Antisense therapeutics in oncology: current status

There is increasing progress in translational oncology and tremendous breakthroughs have been made as evidenced by preclinical and clinical trials. Data obtained from high-throughput technologies are deepening our understanding about the molecular and gene network in cancer cells and rapidly emergin...

Descripción completa

Detalles Bibliográficos
Autores principales: Farooqi, Ammad Ahmad, Rehman, Zia ur, Muntane, Jordi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224095/
https://www.ncbi.nlm.nih.gov/pubmed/25395862
http://dx.doi.org/10.2147/OTT.S49652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224095/
https://www.ncbi.nlm.nih.gov/pubmed/25395862
http://dx.doi.org/10.2147/OTT.S49652

Ejemplares similares